143 related articles for article (PubMed ID: 30263811)
21. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
Bogovič Matijašić B; Obermajer T; Lipoglavšek L; Sernel T; Locatelli I; Kos M; Šmid A; Rogelj I
J Dairy Sci; 2016 Jul; 99(7):5008-5021. PubMed ID: 27157575
[TBL] [Abstract][Full Text] [Related]
22. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
[TBL] [Abstract][Full Text] [Related]
23. Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome.
Stevenson C; Blaauw R; Fredericks E; Visser J; Roux S
Nutrition; 2014 Oct; 30(10):1151-7. PubMed ID: 25194614
[TBL] [Abstract][Full Text] [Related]
24. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial.
Bauserman M; Michail S
J Pediatr; 2005 Aug; 147(2):197-201. PubMed ID: 16126049
[TBL] [Abstract][Full Text] [Related]
25. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
Ludidi S; Jonkers DM; Koning CJ; Kruimel JW; Mulder L; van der Vaart IB; Conchillo JM; Masclee AA
Neurogastroenterol Motil; 2014 May; 26(5):705-14. PubMed ID: 24588932
[TBL] [Abstract][Full Text] [Related]
26. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.
Nobaek S; Johansson ML; Molin G; Ahrné S; Jeppsson B
Am J Gastroenterol; 2000 May; 95(5):1231-8. PubMed ID: 10811333
[TBL] [Abstract][Full Text] [Related]
27. The effects of administration of the Lactobacillus gasseri strain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome.
Nobutani K; Sawada D; Fujiwara S; Kuwano Y; Nishida K; Nakayama J; Kutsumi H; Azuma T; Rokutan K
J Appl Microbiol; 2017 Jan; 122(1):212-224. PubMed ID: 27761980
[TBL] [Abstract][Full Text] [Related]
28. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
Andresen V; Gschossmann J; Layer P
Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):658-666. PubMed ID: 32277872
[TBL] [Abstract][Full Text] [Related]
29. Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon H; Park YS; Lee DH; Seo JG; Shin CM; Kim N
J Clin Biochem Nutr; 2015 Sep; 57(2):129-34. PubMed ID: 26388670
[TBL] [Abstract][Full Text] [Related]
30. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
Kajander K; Hatakka K; Poussa T; Färkkilä M; Korpela R
Aliment Pharmacol Ther; 2005 Sep; 22(5):387-94. PubMed ID: 16128676
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of Bacillus coagulans Unique IS2 in treatment of irritable bowel syndrome in children: a double blind, randomised placebo controlled study.
Sudha MR; Jayanthi N; Aasin M; Dhanashri RD; Anirudh T
Benef Microbes; 2018 Jun; 9(4):563-572. PubMed ID: 29695183
[TBL] [Abstract][Full Text] [Related]
32. Health Benefits of
Nishida K; Sawada D; Kuwano Y; Tanaka H; Rokutan K
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31405122
[TBL] [Abstract][Full Text] [Related]
33. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial.
de Vrese M; Winkler P; Rautenberg P; Harder T; Noah C; Laue C; Ott S; Hampe J; Schreiber S; Heller K; Schrezenmeir J
Clin Nutr; 2005 Aug; 24(4):481-91. PubMed ID: 16054520
[TBL] [Abstract][Full Text] [Related]
34. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.
O'Mahony L; McCarthy J; Kelly P; Hurley G; Luo F; Chen K; O'Sullivan GC; Kiely B; Collins JK; Shanahan F; Quigley EM
Gastroenterology; 2005 Mar; 128(3):541-51. PubMed ID: 15765388
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Probiotic Escherichia coli Nissle 1917 in Patients with Irritable Bowel Syndrome: a Double Blind Placebo-controlled Randomized Trial.
Faghihi AH; Agah S; Masoudi M; Ghafoori SM; Eshraghi A
Acta Med Indones; 2015 Jul; 47(3):201-8. PubMed ID: 26586385
[TBL] [Abstract][Full Text] [Related]
36. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
Pinto-Sanchez MI; Hall GB; Ghajar K; Nardelli A; Bolino C; Lau JT; Martin FP; Cominetti O; Welsh C; Rieder A; Traynor J; Gregory C; De Palma G; Pigrau M; Ford AC; Macri J; Berger B; Bergonzelli G; Surette MG; Collins SM; Moayyedi P; Bercik P
Gastroenterology; 2017 Aug; 153(2):448-459.e8. PubMed ID: 28483500
[TBL] [Abstract][Full Text] [Related]
37. Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults.
Olivares M; Díaz-Ropero MA; Gómez N; Lara-Villoslada F; Sierra S; Maldonado JA; Martín R; López-Huertas E; Rodríguez JM; Xaus J
Int J Food Microbiol; 2006 Mar; 107(2):104-11. PubMed ID: 16271414
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
Choi CH; Jo SY; Park HJ; Chang SK; Byeon JS; Myung SJ
J Clin Gastroenterol; 2011 Sep; 45(8):679-83. PubMed ID: 21301358
[TBL] [Abstract][Full Text] [Related]
39. Yogurt Containing Lactobacillus gasseri Mitigates Aspirin-Induced Small Bowel Injuries: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
Suzuki T; Masui A; Nakamura J; Shiozawa H; Aoki J; Nakae H; Tsuda S; Imai J; Hideki O; Matsushima M; Mine T; Tamura A; Ohtsu T; Asami Y; Takagi A
Digestion; 2017; 95(1):49-54. PubMed ID: 28052291
[TBL] [Abstract][Full Text] [Related]
40. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
Chey WD; Lembo AJ; Lavins BJ; Shiff SJ; Kurtz CB; Currie MG; MacDougall JE; Jia XD; Shao JZ; Fitch DA; Baird MJ; Schneier HA; Johnston JM
Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
